School of Medicine- Course Introduction
Department of Microbiology
Departments of Basic Sciences(Basic Medicine)
In this course, we conduct research into the pathology of infectious diseases from the perspectives of both the pathogen-specific infection mechanism and the host response mechanism against it. In collaboration with the clinical group, we also study the involvement of the bacterial flora in the onset of various diseases. Furthermore, we conduct research leading to the development of vaccines against viral infections and the search for physiologically active substances that control infection immunity.
- Analysis of pathogen-host relationships in infectious diseases
- Elucidation of cellular immunity against varicella-zoster virus
- Searching for bioactive substances that regulate the immune and metabolic systems from natural plants
- Identification of bacterial flora abnormalities in various diseases
Current status of research
Overview
We are analyzing the pathogen-host relationship in infectious diseases with a focus on the major histocompatibility complex (MHC). We are also trying to identify bacterial flora abnormalities in the onset of various diseases. Furthermore, we are creating attenuated influenza virus strains and searching for physiologically active substances derived from natural plants to prevent and treat infectious diseases.
Subject
- We have discovered that MHC, a central molecule in adaptive immunity, is regulated by ubiquitination, and we are investigating diseases caused by abnormalities in this regulation.
- Neutralizing antibodies are often effective in preventing reinfection with the virus, so vaccine effectiveness is often evaluated by antibody titers. However, it has been shown that cellular immunity is important in chickenpox and shingles. We are currently elucidating the details.
- We have been searching for substances that exhibit antiviral, anticancer, and biological activities in glycolipid metabolism and immune-inflammatory control from natural plants, and have found interesting active substances. Currently, we aim to develop new treatments and prevention methods for infectious diseases, cancer, and metabolic syndrome by clarifying their mechanisms of action.
- In collaboration with clinical groups, we aim to identify bacterial dysbiosis involved in inflammatory bowel disease.
Self-evaluation, inspection and future prospects
With a view to the characteristics of pathogens and host responses, we have conducted basic research to develop methods for diagnosing, treating, and preventing infectious diseases and intractable inflammatory diseases. For example, we have demonstrated that (1) MHC class II is regulated by ubiquitination via MARCH-I E3 ubiquitin ligase, (2) that cellular immunity is more important than antibodies in defense against varicella-zoster and chickenpox viruses, (3) that interesting physiologically active substances can be found in natural plants and can suppress inflammation caused by infection, and (4) that there may be abnormalities in the intestinal flora of patients with pouchitis. Based on these results, we will continue to carry out broad and deep research that is directly linked to medicine and healthcare.
Course Information
- Person in Charge
- Satoshi Ishido (Chief Professor)
- Associate Professor
- Shuhei Hayashi
- Associate Professor of Education
- Hideki Ogura
- Lecturer
- Aoi Son
- Course dedicated site
- https://hcm-micro.jimdo.com/